The p73 protein, a member of the p53 family, has both developmental and tumorigenic functions. Here we show that p73 is cleaved by caspase-3 and -8 both in vitro and in vivo during apoptosis elicited by DNA-damaging drugs and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor ligation. TAp73 and some of its cleavage products are localized to mitochondria. siRNA-mediated downregulation of p73 expression induced a small but significant change in the susceptibility of HCT116 cells to TRAIL-induced apoptosis. A transcription-deficient mutant of TAp73 enhanced TRAIL-induced apoptosis suggesting that p73 protein has transcriptionindependent functions during death receptor-mediated apoptosis. Additionally, recombinant p73 protein induced cytochrome c release from isolated mitochondria providing evidence that nonnuclear p73 may have additional functions in the progression of apoptosis.
Introduction
p73 is a p53-related protein implicated in development and tumor suppression (Melino et al., 2003) . The TP73 gene contains two promoters coding for isoforms with or without a transactivation domain, namely TAp73 and DNp73. Each isoform is also subject to extensive alternative splicing at the 3 0 -end of mRNA, resulting in up to 24 transcripts, able to promote or repress apoptosis to different extents (De Laurenzi et al., 1998; Yang et al., 2000) . The proteins originating from the second promoter, DNp73, have a dominant negative activity on the tumor suppressor functions of both TAp73 and p53 and this regulatory loop has been implicated in tumorigenesis (Grob et al., 2001) .
Steady-state p73 protein levels are tightly regulated in the cell (Oberst et al., 2005) . Under normal physiological conditions p73 is degraded either by calpains or by the 26S or 20S proteasomes (Asher et al., 2005; Munarriz et al., 2005; Rossi et al., 2005) . While inhibition of calpains increases the steady-state levels of p73 , the E3 ubiquitin ligase Itch promotes 26S proteasome-dependent p73 degradation . p73 is also subjected to ubiquitinindependent 20S proteasomal degradation that is regulated by NAD(P)H quinone oxidoreductase 1 together with NADH (Asher et al., 2005) . After DNA damage, TAp73 rapidly accumulates (Agami et al., 1999; Gong et al., 1999) predominantly via transcription-independent mechanisms. Indeed, the major determinants regulating p73 accumulation are tyrosine phosphorylation by c-abl, acetylation by p300 and Itch downregulation (Costanzo et al., 2002; Bernassola et al., 2004; Mantovani et al., 2004; Rossi et al., 2005) . Once accumulated, TAp73 transactivates genes like p21, Bax and Puma to induce cell cycle arrest or apoptosis (see Melino et al., 2002 for a review).
p53 has both transcription-dependent and -independent functions to induce apoptosis (Chipuk and Green, 2006) . While most of the proapoptotic activity of p53 is due to its transactivation activity on genes such as Bax, Puma and Noxa (see Toledo and Wahl, 2006 for review), the transcription-independent function of p53 is mostly related to sequestering prosurvival proteins in the cytoplasm to release and activate proapoptotic proteins, Bax or Bak (Leu et al., 2004; Chipuk et al., 2005; Tomita et al., 2006) . Full-length p53 and an N-terminal p53 fragment that is generated by caspase cleavage have been shown to be present in the cytoplasm and mitochondria under apoptotic conditions (Mihara et al., 2003; Sayan et al., 2006) . By analogy to this novel p53-elucidated pathway, we decided to analyse whether p73 is cleaved by caspases and whether this affects its apoptotic activity. Here we show that p73 is cleaved by caspases both in vitro and in vivo. The cleavage of p73 is an early event in response to death-receptor activation and augments tumor necrosis factor-related apoptosisinducing ligand (TRAIL)-induced apoptosis. In support of this concept, we have shown that transcriptionally inactive TAp73 can contribute to apoptosis after being cleaved by caspases. Additionally, we detected fulllength p73 protein in mitochondria by subcellular fractionation and electron microscopy (EM). During TRAIL-induced apoptosis, in addition to full-length p73, a particular p73 fragment is localized to mitochondria. Finally, we demonstrate that recombinant TAp73a induces cytochrome c release from isolated mitochondria providing evidence that p73 has nontranscriptional functions in the progression of apoptosis.
Results and discussion
To characterize p73 protein modifications during both extrinsic and intrinsic pathways of apoptosis, we exposed HCT116 and U2OS cell to TRAIL and etoposide, respectively. We observed the appearance of low molecular weight p73-derived protein products in parallel with caspase-3 activation and poly(ADP-ribose) polymerase (PARP) cleavage (Figure 1 ). Production of these fragments was eliminated by treatment with the pan-caspase inhibitor, Z-Val-Ala-DL-Asp (OMe)-fluoromethylketone (z-VAD-fmk; Figure 1 ). All of the p73 protein was shifted to a slightly lower molecular weight during TRAIL-induced apoptosis (p73 fragment 1, F1), suggestive of a terminal clipping, which was not present upon treatment of U2OS cells with etoposide. On the other hand, we detected a 55 kDa fragment (p73 fragment 2, F2) processed form during etoposideinduced apoptosis but not upon TRAIL treatment (Figure 1) . With both stimuli, a cleavage product of 45 kDa was also present (p73 fragment 3, F3). To ensure that p73 is cleaved by caspases but not by other cysteinyl proteases such as calpains, we pretreated TRAILinduced HCT116 cells with z-VAD-fmk or calpastatin. z-VAD-fmk, but not calpastatin, blocked p73 cleavage confirming that caspases but not calpains were responsible for p73 cleavage during TRAIL-induced apoptosis (Supplementary Figure 1A) .
To identify which caspases may cleave p73, we incubated in vitro translated TAp73a with different recombinant active caspases. All caspases tested (caspase-3, -6, -7 and -8) cleaved p73, with caspase-3 being the most efficient ( Figure 2a ). Since p73 processing was more pronounced upon death receptor-mediated apoptosis ( Figure 1 ) and caspase-3 is implicated both in intrinsic and extrinsic pathways of apoptosis, we focused on caspase-8 and -3. Incubating in vitro translated p73 with increasing amounts of recombinant active caspase-3 and -8 showed that removal of a small peptide from p73 occurred with as low as 20 nM active caspase concentration. In addition, there is at least one more internal cleavage that yields products F2 and F3 ( Figure  2b ; Supplementary Figure 1B) . For mapping these cleavage sites and comparing the efficiency of p73 cleavage with p53 as another caspase substrate, we incubated different isoforms of TAp73, DNp73 and p53 (Figures 2c and d ) with caspase-3. All TAp73 isoforms and DNp73a were cleaved, indicating that the cleavage site/s were in the regions common to both of TAp73 and DNp73. However, close analysis of these cleavage reactions revealed that the N-terminal hemagglutinin (HA) tag in these proteins was also cleaved although the extreme N terminus of DNp73 was retained (Supplementary Figure 1C ). During the preparation of this article, the cleavage of HA tag was also reported (Schembri et al., 2007) . Protein sequencing of in vitro cleavage products and mutating candidate aspartate (Asp) residues, we found that TAp73 is N terminally cleaved after the Asp at amino-acid position 10. Since this part of TAp73 is not shared with DNp73, it is specific for TAp73. It is evident from the data in Figure 2 that there is at least one more cleavage site in p73, most likely in the DNA-binding region, common to all TAp73 isoforms and DNp73 (Figures 2c and d) . Despite mutating all candidate aspartate residues (amino-acid positions 46, 50, 73, 107, 120, 189, 202, 227, 228, 281, 301, 305, 307, 351, 353, 387, 490, 527, 547) to alanine we failed to identify the specific cleavage site/s either because the cleavage site is not a classical caspase recognition site or there may be more than one cleavage site in close proximity, giving a similar banding pattern in western blot. We believe that the second option is more likely because (1) more than 40% of all the aspartates in the p73 protein are located between codons Figure 1 p73 protein is processed during apoptosis. HCT116 cells and U2OS cells were treated with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL, 400 mg ml À1 ) and etoposide (75 mM) in the absence and presence of Z-Val-Ala-DL-Asp (OMe)-fluoromethylketone (z-VAD-fmk, 50 mM). Proteins were resolved on a SDS-polyacrylamide gel electrophoresis (PAGE), transferred to nitrocellulose filters and probed with p73FL, caspase-3 and poly(ADP-ribose) polymerase (PARP) antibodies. Apoptosis was evident in lanes 2 and 5 as caspase-3 was processed yielding p19 and p17 fragments and PARP was cleaved to yield p85. Small molecular weight p73 protein-derived molecules, as marked with F1, F2 and F3, were detected after both treatments and production of these were inhibited by z-VAD-fmk. A nonspecific band appeared at 50 kDa and marked with X. Figure 1D ; Figure 3a ) and (3) the size of the cleavage products (F2: 55 kDa and F3: 45 kDa), which do not add up to 73 kDa (see Figure 3a for a schematic representation). We observed a complete processing of full-length p73 to yield F1 and F3 in HCT116 cells treated with TRAIL ( Figure 1 , lane 2) so we wanted to assess the implications of p73 cleavage in this system. HCT116 cells are type II cells that utilize mitochondrial depolarization after caspase-8 activation to amplify the signal obtained following death receptor ligation (Ozoren and El-Deiry, 2002) . First, to assess the kinetics of p73 cleavage HCT116 were exposed to 200 mg ml À1 TRAIL up to 3 h ( Figure 3b ). The rate of apoptosis, as quantified by cells with a decreased mitochondrial membrane potential, ranged from 12 to 47% (Figure 3b ) during the course of experiment. p73 terminal clipping to from F1 was complete within 1 h of TRAIL treatment, when there is only 12% mitochondrial depolarization but a substantial amount of processed caspase-8 ( Figure 3b ). PARP, Bid and p53 were cleaved in parallel with p73 but their cleavage was not complete after 1 h suggesting that p73 terminal clipping was a very early event during apoptosis ( Figure 3b ). The second cleavage of p73, to yield F3, also started as early as 1 h after TRAIL treatment but continued throughout the time course of the experiment. Low concentrations of z-VAD-fmk (10 mM) inhibit caspase-8 and the extrinsic pathway of apoptosis whereas higher concentrations are required to block the extrinsic pathway (Sun et al., 1999) . To test if caspase-8 activation was required for p73 cleavage, we pretreated HCT116 cells with z-VAD-fmk (10 mM) and exposed the cells to TRAIL. TRAIL-induced activation of caspase-8 and cleavage of p73 were both blocked with 10 mM z-VAD-fmk ( Figure 3c ).
Most caspase targets lose function when they are cleaved during apoptosis (Lamkanfi et al., 2007) , although a small number of proteins acquire a new function after cleavage (Luthi and Martin, 2007) . For example, cleavage of the BH3-only protein Bid by caspase-8 results in its acquisition of a proapoptotic function (Luo et al., 1998) . Similarly, p53 has been shown to enhance mitochondrial depolarization and augment apoptosis after cleavage by caspase-3 (Sayan et al., 2006) . To identify if p73 protein or any of its cleaved products possess a function during TRAILinduced apoptosis, we knocked down p73 by siRNA in HCT116 cells. To obtain a high degree and complete knockdown of all p73 isoforms, we transfected three different oligos simultaneously, one against the 5 0 -region, one for the middle part and one for the 3 0 -region of p73mRNA. We observed more than 95% downregulation of endogenous p73 protein after transfection of p73 siRNAs compared with scrambled siRNA-transfected cells (Figure 4a ). These siRNAs also inhibited the accumulation of p73 upon etoposide and doxorubicin treatment (Figure 4a ). HCT116 cells showed very little mitochondrial depolarization when treated with these DNA-damaging drugs, although p73 protein accumulated as a response to treatment, as did p53 (Sayan et al., 2006) . On the other hand TRAILinduced apoptosis was evident in parallel with p73 cleavage. There was a small but significant (Po0.05) reduction of TRAIL-induced apoptosis in p73siRNA-transfected cells (Figure 4b) , suggesting a function of full-length p73 and/or p73 cleavage fragments in caspase-8-mediated cell death. In a similar fashion, p53 was also shown to be localized to mitochondria as a result of different types of stresses such as irradiation, adriamycin, camptothecin, etoposide or 5-flourouracil treatments, although only 5-fluorouracil-induced apoptosis was clearly described TRAIL. The proteins from these treatments were resolved on SDS-polyacrylamide gel electrophoresis (PAGE) and probed with p73SAM antibody. p73siRNA efficiently downregulated p73 (more than 90%, compare lanes 1 and 5), and also blocked the accumulation of p73 protein upon DNA damage (compare lanes 2, 3 and 6, 7, respectively). The p73 cleavage products observed in lane represented the TRAIL-treated HCT116 cells also disappeared after p73siRNA transfection (compare lanes 4 and 8, the cleavage products are marked with F1 and F3). (b) p73siRNA-transfected HCT116 cells were treated with TRAIL and apoptosis was assessed via mitochondrial depolarization. p73 siRNA-transfected cells showed a small but significant decrease in mitochondrial depolarization compared to scrambled siRNA-transfected cells. The error bars indicate the average of three independent experiments (Po0.05 as assessed by Student's t-test). (c) H1299 cells were transfected with empty pCDNA3, TAp73a and TADp73a together with Mdm2 (or Bax, data not shown) luciferase reporters. The fold induction of luciferase activity on these promoters was measured as compared the luciferase activity detected from control transfection/96 well. TADp73 could not transactivate any of the p73-responsive promoters. (d) HeLa cells were transfected with TAp73a and apoptosis was induced with 400 mg ml À1 of TRAIL. p73 clipping and internal cleavage was evident after the first hour (compare lanes 1 and 2) as detected with p73FL. (e) HeLa cells were transfected with empty pCDNA3.1 vector, TAp73a and TADp73a. TRAIL-induced apoptosis was assessed after 6 h and etoposide-induced apoptosis was assessed after 24 h treatment by mitochondrial depolarization. TADp73 did not contribute to etoposide-induced apoptosis whereas TAp73a contributed to both TRAIL-and etoposide-induced apoptosis as compared to control. On the other hand, more apoptosis was observed in TADp73-transfected cells compared to control after TRAIL treatment. The error bars indicate the average of three independent experiments (Po0.05 as assessed by Student's t-test).
to be p53 dependent (Marchenko et al., 2000; MahyarRoemer et al., 2004; Essmann et al., 2005; Sayan et al., 2006) . p73-induced apoptosis requires transcription of several proapoptotic genes, such as Bax and PUMA (Melino et al., 2002 . p53 has been shown to have transcription-independent activities promoting apoptosis predominantly via binding to prosurvival proteins like Bcl-XL, causing the release of proapoptotic proteins like Bax following apoptotic stimuli (Chipuk et al., 2003; Leu et al., 2004; Tomita et al., 2006) . Since TRAIL-induced apoptosis proceeds via direct activation of caspase-8 and effector caspases without any necessity for transcription, we investigated whether p73-induced transcription was essential for TRAIL-induced apoptosis. For this reason, we generated a transcriptionally deficient p73 (TADp73) having the amino-acid substitution p73R293H that corresponds to p53R273H. Our initial studies confirmed that TADp73 is transcriptionally inactive on several p73-responsive promoters like Mdm2 and Bax (Figure 4c ; data not shown for Bax). To see the effect of TAp73 and TADp73, we transfected TAp73a to HeLa cells and exposed them to TRAIL for 1, 3 and 6 h. p73 was cleaved efficiently in this system as the cleavage products were present after 1 h of TRAIL treatment ( Figure 4d) . As a next step we transfected pCDNA3, TAp73 and TADp73 to HeLa cells. Both TAp73 and TADp73 cells showed more mitochondrial depolarization compared with control cells, suggesting that the presence of the TAp73 protein, regardless of its transactivation ability, was contributing to TRAILinduced apoptosis (Figure 4e ). Transcription-deficient p73 (DNp73 or TADp73) was shown to inhibit apoptosis by directly blocking the p53 response elements on genomic DNA or by oligomerizing with p53 or TAp73 and inhibiting their transactivation activity (Grob et al., 2001; Stiewe et al., 2002) . Thus, TADp73 or cleaved p73 fragments should have a transcriptionindependent effect during TRAIL-induced apoptosis. These results also confirmed our findings of Figures 4a and b with a reverse approach where we observed the absence of p73 to have a negative effect on TRAILinduced apoptosis. On the other hand TAp73, but not TADp73, significantly enhanced etoposide-induced mitochondrial depolarization relative to the control emphasizing the importance of p73-dependent transactivation of proapoptotic genes in etoposide-induced apoptosis (Figure 4e) .
To mimick the caspase-cleaved p73 fragments and map any mitochondrial localization sequences in p73 protein, we cloned DNA-binding domain (DBD, amino acids 95-412) and C-terminal domain (CTD, amino acids 396-636) of p73 as two overlapping parts. None of these fragments induced mitochondrial depolarization alone when ectopically expressed in HeLa cells (Supplementary Figure 2A) . Surprisingly, the CTD-p73 was predominantly localized to mitochondria whereas DBD-p73 was predominantly detected in the cytoplasmic/nuclear fraction (Supplementary Figure 2B) . p73-F1, representing the cleavage at Asp 10 (amino acids 11-636), was detected in mitochondrial and extramitochondrial fraction as full-length p73 (Supplementary Figure 2B ). p73-F1 also possessed all the apoptotic activity of full-length p73 (data not shown), possibly because it retained a significant portion of the transactivation ability of full-length TAp73 (Supplementary Figure 2A ; data not shown). These results showed that p73 localization to mitochondria is a complex process, which may require the interaction of more than one protein with the full-length p73 and/or p73 fragments.
As a next step, we wished to see if p73, like p53, was physically present in/on the mitochondria and if it acquires a nontranscriptional function therein. We treated endogenous p73 expressing HCT116 cells with TRAIL and isolated mitochondria. Endogenous fulllength TAp73 was detected in mitochondria in both untreated and TRAIL-treated cells by western blotting (Figure 5a ). Additionally, we detected F3 as a doublet, very close to 45 kDa, in mitochondrial and extramitochondrial fractions after the induction of apoptosis (Figure 5a ). Subcellular fractionation always raises the question of contamination between fractions so we wanted to assess the mitochondrial presence of p73 by another method. Similar fractions were prepared for preembedding immunogold EM and individual mitochondria were identified by their characteristic ultrastructure. The isolation of mitochondria frequently results in discontinuities in their membranes, allowing access of the immunogold reagents and labeling of the intermembrane space and matrix with antibodies to cytochrome c and mitochondrial Hsp70, respectively (Figure 5b ; data not shown for cytochome c). Our immunogold results also showed the presence of fulllength TAp73a within the mitochondrial matrix (Figure 5b ). To analyse the functional consequences of p73 localization to mitochondria, isolated rat liver mitochondria were incubated with full-length recombinant TAp73a and assessment of cytochrome c release was performed by western blotting. Incubation of mitochondria with p73 resulted in the release of cytochrome c (Figure 5c ). However, in the presence of the calcium chelator ethylene glycol tetraacetic acid this release was suppressed dramatically, indicating that the release of cytochrome c could be mediated by Ca 2 þ -dependent mitochondrial permeability transition (MPT) due to opening of nonspecific pores in the inner mitochondrial membrane. To test this possibility, TAp73a was added to Ca 2 þ -loaded mitochondria and induction of MPT was assessed by the release of accumulated Ca 2 þ from mitochondria using a Ca 2 þ -sensitive electrode. The data show that p73 stimulated MPT in a concentration-dependent manner suggesting that it is p73 dependent (Figure 5d) . Finally, as a followup of the descriptions suggesting that full-length p53 is localized to mitochondria we wanted to see if p73 and p53 interact in/on mitochondria. For this reason we transfected the p53-null H1299 cell line with p73 and/or p53, isolated the mitochondrial fractions and immunoprecipitated p53-bound protein complexes. We detected full-length p73 as an interacting partner of mitochondrial p53 (Supplementary Figure 2C) . 
Concluding remarks
We have shown that p73 is cleaved by caspases during apoptosis. p53, a p73 homologue, is also cleaved by caspases during apoptosis to yield peptides localizing to mitochondria and inducing mitochondrial depolarization (Sayan et al., 2006) . In a similar manner, p73 is cleaved after Asp at position 10 and at two different, but nonclassical, sites between amino acids 250-350, which leads to the generation of two C-terminal fragments probably containing a nuclear localization signal, oligomerization and sterile alpha motif (SAM) domains. Additionally, we have identified full-length p73, p73-F1 and a C-terminal fragment of p73 in the mitochondria by cellular fractionation, at least partly complexed with p53, and confirmed the presence of TAp73 in mitochondria by EM. An endogenous p73 fragment was present in mitochondria in TRAIL-treated apoptotic cells. Incubation of isolated mitochondria with purified recombinant full-length TAp73a induced the release of cytochrome c providing evidence that p73 possesses/ acquires nontranscriptional roles during apoptosis directly by inducing the release of proteins from mitochondria.
Since we have shown previously that some caspasegenerated p53 fragments localize to mitochondria (Sayan et al., 2006) , and p53 and p73 are known to heterooligomerize, we investigated whether p73 and p53 were physically associated in mitochondria. Our results indicated that these two proteins can actually interact in/ on mitochondria providing one potential explanation for the presence of p73 or p73 fragments in mitochondria.
p73 has been shown to interact with Wwox tumor suppressor protein by binding to its WW domain À1 tumor necrosis factor-related apoptosisinducing ligand (TRAIL) for 6 h. P73-SAM antibody was used to detect the p73 cleavage products in total, mitochondrial and cytoplasmic/nuclear (c/n) fractions. Anti-actin, Cox2 and proliferating cell nuclear antigen (PCNA) antibodies were used to check the purity of the fractions. p73 cleavage forms F1 and F3 were marked accordingly. Endogenous full-length p73 protein was detected in mitochondria under normal and apoptotic conditions. The cleavage product/s band resolving around 45 kDa (marked with F3 previously) in SDS-polyacrylamide gel electrophoresis (PAGE) appeared to comprise two bands, one of which resides in mitochondria and the other in the c/n fraction exclusively. ) were loaded with 80 nmol of Ca 2 þ in the presence and absence of TAp73 and Ca 2 þ release as a marker of MPT was monitored. 1, control; 2, 2 mg TAp73; 3, 4 mg TAp73a.
p73 localizes to mitochondria AE Sayan et al through the PPXY motif located at the p73 C terminus (amino acids between 482 and 488; Aqeilan et al., 2004) . Although we could not map the internal cleavage sites in p73, all detected p73 fragments (F1, F2 and F3) should contain the PPXY motif as they are detected by p73SAM antibody that is raised against amino-acid residues 487-554 of TAp73a. This interaction induces the shuttle of p73 from nucleus to cytoplasm in an Srcdependent manner and increases the apoptotic activity of Wwox protein (Aqeilan et al., 2004) . Therefore, a further possibility is that p73 or p73 cleavage fragments migrate to the cytoplasm/mitochondria following interaction with WW domain containing proteins.
In a parallel study, we recently showed that the third p53 family member, p63, is a caspase target (Sayan et al., 2007) . Unlike p73 and p53, p63 is cleaved at a single site near to its C terminus (after Asp at codon 458 of TAp63), deleting the transcription inhibition domain and giving rise to a transcriptionally more active TAp63 fragment.
The response to death receptor-induced apoptosis depends on the condition of the cell where component genes of the death receptor pathway are upregulated via transactivation. A good example of this is the ability of p53 and p73 to upregulate the expression of KILLER/ DR5 and several caspases (Takimoto and El-Deiry, 2000; MacLachlan and El-Deiry, 2002; Muller et al., 2005) . So, if either TAp73 or p53 is present in a cell, that cell can be considered as already preconditioned for death receptor-mediated apoptosis. The TP53 gene is mutated and mutant p53 protein is accumulated in at least 50% of cancers (Sigal and Rotter, 2000) . On the other hand, the TP73 gene is very rarely mutated and overexpression of TAp73 is often observed in tumors (Zaika et al., 1999; Stiewe and Putzer, 2000; Sayan et al., 2001; Muller et al., 2005) . The new transcriptionindependent function of p73 and p53 (Sayan et al., 2006) suggests new approaches to chemotherapy, which do not require transcriptionally active p53 family members.
Materials and methods
Cell culture and drug treatments H1299, HeLa, U2OS and HCT116 cells were grown as suggested by American Type Culture Collection. Transfections were carried out by Lipofectamine-2000 reagent (Invitrogen, UK). Cell lines were treated with 50-75 mM of etoposide, 0.5 mM doxorubicin or 100-400 mg ml À1 TRAIL for induction of apoptosis. z-VAD-fmk (10-50 mM; Bio-Mol, Exeter, UK) or calpeptin (Sigma, UK) was added freshly to the growth medium 1 h prior to drug treatments. Analysis of mitochondrial membrane depolarization with TMRE was assessed by flow cytometry as described before (Sayan et al., 2006) .
Plasmids
Human TAp73a, -b, -g, DNp73a and p53 encoding pCDNA3 plasmids containing an N-terminal HA tag were described previously (De Laurenzi et al., 1998; Sayan et al., 2006) . Stratagene QuickChange sitedirected mutagenesis kit was used to mutate candidate aspartate residues. P73-CTD and p73-DBD were kindly provided by Dr V De Laurenzi. p53 reporter plasmids used in luciferase assays were described previously (Sayan et al., 2006) . p73-F1(11-636) and p73(D10A) were generated without HA tag in pCDNA3. In vitro transcription translation of p53 and p73 plasmids and in vitro caspase cleavage assays were described previously (Sayan et al., 2006) .
Antibodies, immunoblot analysis and cellular fractionation Equal numbers of cells were sonicated in 2 Â Laemmli buffer and boiled at 95 1C for 5 min. Anti-p73 antibodies, p73FL, p73SAM and anti-DNp73 were used to detect p73 and/or p73 fragments as indicated in the article . The anti-caspase-3 antibody was a kind gift from Dr XM Sun and the anti-PARP antibody was from Alexis. The anti HA-tag antibody was purchased from Sigma (clone HA-7). Cells were fractionated and the purity of fractions was assessed as described before (Sayan et al., 2006) . Anti-cytochrome c was from Pharmingen (CA, USA) (clone 6H2.B4) and anti-mHSP70 was obtained from Abcam (clone JG1).
Immunoprecipitation from mitochondrial extracts One 14 cm plate of H1299 cells was transfected with flagtagged p53 or HA-tagged p73 alone and with both. Cells were pelleted for mitochondria preparation as described above 36 h after transfection. Mitochondrial pellets were resuspended and sonicated in lysis buffer containing 50 mM Tris, 1 mM EDTA, 150 mM NaCl and 0.1% NP-40. Following the verification of the purity of mitochondrial fractions, immunoprecipitation of mitochondrial p53-bound protein complexes was done by incubating the lysates with anti-flag antibody (clone M2, Sigma) and precipitating with protein G sepharose. The complexes were resolved on SDS-polyacrylamide gel electrophoresis (PAGE) and probed for the presence of p73 protein by using horseradish peroxidaseconjugated anti-HA antibody to avoid the immunoglobulin band.
Electron microscopy
The mitochondrial fraction from TAp73a-transfected H1299 cells was fixed with 4% paraformaldehyde and washed with phosphate-buffered saline/normal goat serum/bovine serum albumin/Tween 20 before overnight incubation in the primary antibody (p73FL, cytochome c and mHSP70). A subsequent incubation in the secondary antibody, conjugated with 10 nm colloidal gold (BBI, Cardiff, UK), was followed by fixation in 2% glutaraldehyde followed by 1% osmium tetroxide/1% potassium ferrocyanide. All samples were embedded in epoxy resin and ultra-thin sections were examined, unstained, in a Zeiss 902A electron microscope.
p73 localizes to mitochondria AE Sayan et al
Isolation of rat liver mitochondria and cytochrome c release assay The liver of a male Sprague-Dawley rat was minced on ice, resuspended in 50 ml of MSH buffer (210 mM mannitol, 70 mM sucrose, 5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.5) supplemented with 1 mM EDTA, and homogenized with a glass Dounce homogenizer and Teflon pestle. Homogenates were centrifuged at 600 g for 8 min at 4 1C. The supernatant was decanted and recentrifuged at 5500 g for 15 min to form a mitochondrial pellet that was resuspended in MSH buffer without EDTA and centrifuged again at 5500 g for 15 min. The final mitochondrial pellet was resuspended in MSH buffer at a protein concentration of 80-100 mg ml À1 . Fresh mitochondria were prepared for each experiment and used within 4 h. Incubation of isolated mitochondria was performed in buffer containing 150 mM KCl, 1 mM KH 2 PO 4 , 5 mM succinate and 5 mM Tris (pH 7.4) at 25 1C. Ca 2 þ fluxes across the inner mitochondrial membrane were monitored using a Ca 2 þ -sensitive electrode (model 97-20, Orion Research Inc., Beverly, MA, USA). Rotenone (2 mM) was added to maintain pyridine nucleotides in a reduced form.
To analyse cytochrome c release, isolated mitochondria were resuspended in the incubation buffer at a concentration of 1 mg of protein per ml. Mitochondrial suspension were aliquoted (100 ml) in eppendorf tubes containing recombinant TAp73a and incubated for 20 min at room temperature. The mitochondria were spun down, the supernatants decanted and the pellets were resuspended in 100 ml of the incubation buffer. Samples were mixed with Laemmli loading dye, boiled for 5 min and subjected to western blot analysis. Recombinant p73 was prepared as described before .
Abbreviations
Cox II, cytochrome c oxidase-complex IV subunit II; HA, hemagglutinin-HA epitope; PARP, poly(ADP-ribose) polymerase; TRAIL, tumor necrosis factor-related apoptosisinducing ligand; z-VAD-fmk, Z-Val-Ala-DL-Asp (OMe)-fluoromethylketone.
